The Gynecologic Oncology Institute focuses on ovarian cancer and supports all efforts to get care back to normal as soon as possible. This is another form of collateral damage due to the pandemic and it certainly hits our patients close to home. Cancer Manag Res. 2021, Jan. 14; 13: 359-366. doi: 10.2147 / CMAR.S287152. eCollection […]

Survival

Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact

Dr Steve Vasilev MD - September 18, 2017 0

The following is a press release from Caris Life Sciences about a breakthrough presentation of data at the recent American Society for Clinical Oncology (ASCO) meeting. In this study, the median overall survival was eight years longer in ovarian and fallopian tube cancer patients treated using Caris Molecular Intelligence profiling vs. those who did not....

Survival

Most breast and ovarian cancer patients not undergoing genetic testing study finds

Antibody immunity found in ovarian cancer

Oxford ovarian cancer classification system: predicting survival outcomes

ARID1A molecular driver of some ovarian cancers and glutamine benefits and harm

Ovarian cancer aggressive treatment can help older patients

Most Read

Most breast and ovarian cancer patients not undergoing genetic testing study finds

HPV Vaccines Lead to Fewer Cervical Precancers: CDC

Primary peritoneal cancer and advanced ovarian serous cancer: A difference in prognosis says new SEER data analysis

Endometriosis: Any New Tests?

ABOUT US

FOLLOW US